Home » Newsletters » The Carlat Psychiatry Report

The Carlat Psychiatry Report

Stopping Psych Meds Part 2 (March) | 2021

View Archived Issues

Learning Objectives, Stopping Psych Meds Part 2, TCPR, March 2021

March 11, 2021

After reading these articles, you should be able to… Read More

Stopping Psych Meds Part 2 TCPR, March 2021

March 11, 2021

By successfully completing the test you will be awarded a certificate for 1 CME credit. Read More

TMS Treatment for Depression: An Update

March 11, 2021

Adam Strassberg, MD.

Transcranial magnetic stimulation is no longer just for depression, with 6 FDA approvals and 7 different devices to choose from. Adam Strassberg looks at how well this intervention stacks up against ECT and medications. Includes a buyer’s guide to the latest machines. Read More

How to Come Off a Psych Med Part 2: Antidepressants, Stimulants, and Benzos

March 11, 2021

Swapnil Gupta, MD

What do you do when a patient comes to you on a high dose of Adderall and Klonopin without any clear reason to be on them? Swapnil Gupta tackles this in part II of our interview on deprescribing, and describes how to fine-tune and microdose antidepressants and benzodiazepines to manage withdrawal symptoms. Read More

A Closer Look at Alpha-2 Agonists for ADHD

March 11, 2021

Jason Mallo, DO

Now that guanfacine ER (Intuniv) and clonidine ER (Kapvay) have gone generic, we review the 40-years of research that earned them FDA approval in ADHD. Along the way we’ll consider their off-label use in anxiety, addiction, insomnia, and self-harm. Plus: When to use the ER, the instant release, or the oft-forgotten transdermal patch. Read More

Antipsychotic Use Associated With Increased Risk of Mortality

March 11, 2021

Michael Posternak, MD.

The study is not without flaws, but it raises some concerns about the long term health-effects of antipsychotic augmentation. Read More

In Brief: Who Needs the Therapeutic Alliance?

March 11, 2021

Chris Aiken, MD

Oxytocin levels tend to fluctuate in synchrony when people are in strong, connected relationships, from the mother-child bond to romantic partnerships. A new study extended that to the therapist-patient dyad by comparing the change in oxytocin levels for patient and therapist during each session of psychotherapy for depression. The greater the synchrony in the oxytocin flux, the better the therapy outcomes. Read More